NASDAQ:BFRI

Biofrontera Stock Insider Trading

Healthcare > Drug Manufacturers - Specialty & Generic

Buy BFRI

*Your capital is at risk

$1.24

+0.0200 (+1.64%)

At Close: Aug 05, 2026

Biofrontera Stock Insider Power

Based on the 100 latest insides trades, we have calculated the insider power to be positive at 100.00. In total, the insiders bought 53.49M and sold 0 BFRI shares in the last 100 trades. The insider score can be negative despite buy/sell ratio being positive. The score focuses on the quality of the trades.

Insider Power (Last 100 transactions)	100.00
● Buy	53.49M shares
● Sell	0 shares
100% Buy Activity Negligible or No Correlation
No Significant Signals No statistically significant buy or sell signals detected in recent insider data.

Historical Insider Trades

Date	Type	Person	Role	Amount
Sep 16, 2025 Buy	Common Stock J-Other	Plaggemars Hansjoerg	10% Owner	0 Value: $0
Sep 16, 2025 Buy	Common Stock J-Other	Link Christian Alexander Ansgar	10% Owner	0 Value: $0
Sep 16, 2025 Buy	Common Stock	Vv Beteiligungen Aktiengesellschaft 10 Percent Owner	10% Owner	0 Value: $0
Sep 16, 2025 Buy	Common Stock	Vv Beteiligungen Aktiengesellschaft 10 Percent Owner	10% Owner	0 Value: $0
Sep 16, 2025 Buy	Series D Convertible Preferred Stock	Vv Beteiligungen Aktiengesellschaft 10 Percent Owner	10% Owner	4 831 172 Value: $3.02M
Sep 16, 2025 Buy	Common Stock	Delphi Unternehmensberatung Aktiengesellschaft 10 Percent Owner	10% Owner	0 Value: $0
Sep 16, 2025 Buy	Common Stock	Delphi Unternehmensberatung Aktiengesellschaft 10 Percent Owner	10% Owner	0 Value: $0
Sep 16, 2025 Buy	Series D Convertible Preferred Stock	Delphi Unternehmensberatung Aktiengesellschaft 10 Percent Owner	10% Owner	4 831 172 Value: $3.02M
Sep 16, 2025 Buy	Common Stock J-Other	Plaggemars Hansjoerg	10% Owner	0 Value: $0
Sep 16, 2025 Buy	Common Stock	Zours Wilhelm Konrad Thomas 10 Percent Owner	10% Owner	0 Value: $0
Sep 16, 2025 Buy	Common Stock	Zours Wilhelm Konrad Thomas 10 Percent Owner	10% Owner	0 Value: $0
Sep 16, 2025 Buy	Series D Convertible Preferred Stock	Zours Wilhelm Konrad Thomas 10 Percent Owner	10% Owner	4 831 172 Value: $3.02M
Sep 16, 2025 Buy	Common Stock	Deutsche Balaton Aktiengesellschaft 10 Percent Owner	10% Owner	0 Value: $0
Sep 16, 2025 Buy	Common Stock	Deutsche Balaton Aktiengesellschaft 10 Percent Owner	10% Owner	0 Value: $0
Sep 16, 2025 Buy	Series D Convertible Preferred Stock	Deutsche Balaton Aktiengesellschaft 10 Percent Owner	10% Owner	4 831 172 Value: $3.02M
Sep 16, 2025 Buy	Common Stock	Zours Wilhelm Konrad Thomas 10 Percent Owner	10% Owner	0 Value: $0
Sep 16, 2025 Buy	Common Stock	Zours Wilhelm Konrad Thomas 10 Percent Owner	10% Owner	0 Value: $0
Sep 16, 2025 Buy	Series D Convertible Preferred Stock	Zours Wilhelm Konrad Thomas 10 Percent Owner	10% Owner	4 831 172 Value: $3.02M
Sep 16, 2025 Buy	Common Stock	Deutsche Balaton Aktiengesellschaft 10 Percent Owner	10% Owner	0 Value: $0
Sep 16, 2025 Buy	Common Stock	Deutsche Balaton Aktiengesellschaft 10 Percent Owner	10% Owner	0 Value: $0
Sep 16, 2025 Buy	Series D Convertible Preferred Stock	Deutsche Balaton Aktiengesellschaft 10 Percent Owner	10% Owner	4 831 172 Value: $3.02M
Sep 16, 2025 Buy	Common Stock	De La Huerta Martinez Maria Del Pilar	Director	0 Value: $0
Sep 16, 2025 Buy	Series D Convertible Preferred Stock	De La Huerta Martinez Maria Del Pilar	Director	4 831 172 Value: $3K
Sep 16, 2025 Buy	Common Stock	De La Huerta Martinez Maria Del Pilar	Director	0 Value: $0
Sep 16, 2025 Buy	Series D Convertible Preferred Stock	De La Huerta Martinez Maria Del Pilar	Director	4 831 172 Value: $3K

About Insider Power

Insider Power is a proprietary algorithm developed by StockInvest.us to evaluate the significance of insider transactions. The calculation considers the size, type, and timing of transactions, as well as the insider’s role within the company.

It is important to note that, in general, there is little to no correlation between insider transactions and short-term stock price movements. In one of our studies, only 0.22%^* of stocks with insider activity showed a measurable correlation — and even then, it was unclear whether the effect was caused by insider actions or simply by the stock’s broader trend.

While our algorithms are designed to highlight potentially meaningful signals, these cannot be regarded as statistically significant on their own. Insider trading activity should therefore be seen as informative rather than as direct trading guidance. The Insider Power metric was created to present this information in a clearer and more accessible way, helping investors better understand the possible context of insider activity.

* October 6th, 2025 - Tested on 5562 stocks

ABOUT BIOFRONTERA INC.

Biofrontera Inc., a biopharmaceutical company, engages in the commercialization of pharmaceutical products for the treatment of dermatological conditions in the United States. The company offers Ameluz, which is a prescription drug approved for use in combination with the company's licensor's medical device; and the RhodoLED lamp series for photodynamic therapy for the lesion-directed and field-directed treatment of actinic keratosis of mild-to-m...

Read Full Profile Here